DENTALKART

Vasa Denticity Share Price

₹732.45 +11.15 (1.55%)

28 Dec, 2024 01:26

SIP TrendupStart SIP in DENTALKART

Start SIP

Performance

  • Low
  • ₹725
  • High
  • ₹736
  • 52 Week Low
  • ₹401
  • 52 Week High
  • ₹840
  • Open Price₹725
  • Previous Close₹721
  • Volume9,750

Investment Returns

  • Over 1 Month + 17.32%
  • Over 3 Month + 30.79%
  • Over 6 Month + 20.67%
  • Over 1 Year + 15.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Vasa Denticity for Steady Growth!

Invest Now

Vasa Denticity Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 69.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 1,218
  • P/B Ratio
  • 17.8
  • Average True Range
  • 37.43
  • EPS
  • 10.97
  • Dividend Yield
  • 0
  • MACD Signal
  • 24.98
  • RSI
  • 50.17
  • MFI
  • 34.16

Vasa Denticity Financials

Vasa Denticity Technicals

EMA & SMA

Current Price
₹732.45
+ 11.15 (1.55%)
pointer
  • stock-down_img
  • Bullish Moving Average 9
  • stock-up_img
  • Bearish Moving Average 7
  • 20 Day
  • ₹741.20
  • 50 Day
  • ₹701.59
  • 100 Day
  • ₹659.84
  • 200 Day
  • ₹612.13

Resistance and Support

731.17 Pivot Speed
  • R3 748.08
  • R2 742.02
  • R1 737.23
  • S1 726.38
  • S2 720.32
  • S3 715.53

What's your outlook on Vasa Denticity?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

asa Denticity specializes in manufacturing and distributing dental care products, including equipment, instruments, and consumables. It serves dental professionals and clinics across India, providing high-quality solutions to support oral healthcare and dental practices.

Vasa Denticity Ltd has an operating revenue of Rs. 207.43 Cr. on a trailing 12-month basis. An annual revenue growth of 40% is outstanding, Pre-tax margin of 11% is healthy, ROE of 22% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 21% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 90 which is a GREAT score indicating consistency in earnings, a RS Rating of 71 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 18 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vasa Denticity Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-05-16 Audited Results
2023-11-03 Quarterly Results

Vasa Denticity F&O

Vasa Denticity Shareholding Pattern

69.62%
0.02%
25.37%
4.99%

About Vasa Denticity

  • NSE Symbol
  • DENTALKART
  • BSE Symbol
  • Chairman & Managing Director
  • Dr. Vikas Agarwal
  • ISIN
  • INE0N5801013

Similar Stocks to Vasa Denticity

Vasa Denticity FAQs

Vasa Denticity share price is ₹732 As on 28 December, 2024 | 01:12

The Market Cap of Vasa Denticity is ₹1217.5 Cr As on 28 December, 2024 | 01:12

The P/E ratio of Vasa Denticity is 69.3 As on 28 December, 2024 | 01:12

The PB ratio of Vasa Denticity is 17.8 As on 28 December, 2024 | 01:12

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23